Immune Modulation & Natural Biocompounds

Dr. Dorit Avni

Principal Researcher

Dr. Dorit Avni

Dr. Dorit Avni
Immune Modulation & Natural Biocompounds
054-9815556

We strive to understand the mechanisms of  inflammation and cancer  that underlie the involvement of sphingolipids  and to translate these laboratory discoveries into new therapies

 

Latest Publications

Young green quinoa as a sustainable functional crop with anti-inflammatory effects

Hamdan Khattib, Noam Pintel, Soliman Khatib, Lior Rubinovich & Dorit Avni
Nature Sci Rep 15, 20308 (2025).
2025

p70S6K as a Potential Anti-COVID-19 Target: Insights from Wet Bench and In Silico Studies

Shechter, S., Kumar, R., Trovato, F., Rozen, O., Gage, M. J. & Avni, D.
Cells 13(21)
2024

Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors. Immunol Lett

Katz S, Ernst O, Avni D, Athamna M, Philosoph A, Arana L, Ouro A, Hoeferlin LA, Meijler MM, Chalfant CE, Gómez-Muñoz
2016

Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J

Huang WC, Liang J, Nagahashi M, Avni D, Yamada A, Maceyka M, Wolen AR, Kordula T, Milstien S, Takabe K, Oravecz T, Spiegel S.
2016